Literature DB >> 2766908

Effects of cisapride on postcibal jejunal motor activity.

G Stacher1, G Gaupmann, H Steinringer, C Schneider, G Stacher-Janotta, G Steiner-Mittelbach, T A Abatzi.   

Abstract

In the jejunum of fasting humans, cisapride induces a phase 2-like, highly propagative motor pattern. This study investigated cisapride's effects on the fed pattern of the jejunum. Starting 5 min after a phase 3 of the migrating motor complex, 18 healthy men received 5 or 10 mg cisapride or placebo orally in random double-blind fashion and ingested meals containing 1000 and 4200 kJ, respectively. Jejunal pressures were recorded pneumohydraulically with five catheter orifices 10-30 cm aboard the ligament of Treitz. After the 4200-kJ meal, total number and number of propagated contractions as well as area under the curve increased significantly more than after 1000 kJ. Following the 1000-kJ but not the 4200-kJ meal, 10 mg cisapride increased total number of contractions, number of propagated contractions, mean amplitude, and area under curve significantly more than placebo. Fed-pattern duration increased with the meal's caloric content but was not influenced systematically by cisapride. In conclusion, cisapride stimulates jejunal motor activity and induces a propagative pattern after a 1000-kJ but not after a 4200-kJ meal, suggesting that it can produce no further stimulation when motor activity is near maximally enhanced already.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766908     DOI: 10.1007/BF01538077

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  8 in total

1.  Relationship of motility to flow of contents in the human small intestine.

Authors:  P Kerlin; A Zinsmeister; S Phillips
Journal:  Gastroenterology       Date:  1982-04       Impact factor: 22.682

2.  Effects of oral cisapride on interdigestive jejunal motor activity, psychomotor function, and side-effect profile in healthy man.

Authors:  G Stacher; G Gaupmann; G Mittelbach; C Schneider; H Steinringer; B Langer
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

3.  Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.

Authors:  M Camilleri; M L Brown; J R Malagelada
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

4.  Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa.

Authors:  G Stacher; H Bergmann; S Wiesnagrotzki; A Kiss; C Schneider; G Mittelbach; G Gaupmann; J Höbart
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

5.  Ceruletide increases dose dependently both jejunal motor activity and threshold and tolerance to experimentally induced pain in healthy man.

Authors:  G Stacher; H Steinringer; G Schmierer; C Schneider; S Winklehner; G Mittelbach; C De Paolis; C Praga
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

6.  Disruptive effect of test meals on interdigestive motor complex in dogs.

Authors:  I De Wever; C Eeckhout; G Vantrappen; J Hellemans
Journal:  Am J Physiol       Date:  1978-12

7.  Effects of cisapride on jejunal motor activity in fasting healthy humans.

Authors:  G Stacher; H Steinringer; C Schneider; S Winklehner; G Mittelbach; G Gaupmann
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

8.  Variability of motility of the ileum and jejunum in healthy humans.

Authors:  P Kerlin; S Phillips
Journal:  Gastroenterology       Date:  1982-04       Impact factor: 22.682

  8 in total
  5 in total

1.  Daytime and night time motor activity of the small bowel after solid meals of different caloric value in humans.

Authors:  J Schönfeld; D F Evans; D L Wingate
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

2.  Effects of cisapride on gastrointestinal transit in healthy humans.

Authors:  J L Madsen
Journal:  Dig Dis Sci       Date:  1990-12       Impact factor: 3.199

Review 3.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

4.  Cisapride in treatment of Roux-en-Y syndrome.

Authors:  H C van der Mijle; H Beekhuis; R P Bleichrodt; J H Kleibeuker
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

Review 5.  Treating nausea and vomiting in palliative care: a review.

Authors:  Paul Glare; Jeanna Miller; Tanya Nikolova; Roma Tickoo
Journal:  Clin Interv Aging       Date:  2011-09-12       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.